Werb Daniel, Elliott Richard, Fischer Benedikt, Wood Evan, Montaner Julio, Kerr Thomas
HIV AIDS Policy Law Rev. 2007 Dec;12(2-3):12-7.
Drug treatment courts (DTCs), which are judicially mandated treatment alternatives to the incarceration of illicit drug offenders, were introduced in Canada in late 1998. Recent announcements from the federal government suggest that the drug treatment court model will continue to operate and expand in a number of Canadian jurisdictions. Two major evaluations of these programs--in Vancouver and Toronto--have been conducted. In this article, D. Werb et al. analyze the results of these evaluations. Their analysis reveals that, despite the evaluations, little is known regarding the success of DTCs in contributing to the long-term reduction of drug use and recidivism among their participants; and that the cost-effectiveness of these programs requires further study. The authors conclude that further funding for DTCs in Canada should be dependent on the implementation of randomized controlled trials that measure the success of these programs in reducing drug use and recidivism in the long term; that measure the impact of DTCs on societal end-points such as rates of crime and incarceration of injection drug users; and that include components to measure the cost-effectiveness of DTCs compared with other interventions aimed at reducing the negative effects of problematic drug use and drug-related crime.
药物治疗法庭(DTCs)于1998年末在加拿大引入,它是司法规定的针对非法药物犯罪者监禁的替代治疗方式。联邦政府近期发布的消息表明,药物治疗法庭模式将在加拿大的多个司法管辖区继续运作并扩大。已经对这些项目在温哥华和多伦多进行了两项主要评估。在本文中,D. 韦布等人分析了这些评估结果。他们的分析显示,尽管进行了评估,但对于药物治疗法庭在促使参与者长期减少药物使用和再犯罪方面的成效知之甚少;并且这些项目的成本效益需要进一步研究。作者们得出结论,加拿大对药物治疗法庭的进一步资助应取决于开展随机对照试验,这些试验要衡量这些项目在长期减少药物使用和再犯罪方面的成效;衡量药物治疗法庭对诸如犯罪率和注射吸毒者监禁率等社会终点的影响;并且要包含一些组成部分来衡量与旨在减少问题性药物使用和与药物相关犯罪负面影响的其他干预措施相比,药物治疗法庭的成本效益。